Anchiano Therapeutics Company
Anchiano is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat cancer.
Technology:
Anti-infective Drugs
Industry:
PharmTech
Headquarters:
Jerusalem, Yerushalayim, Israel
Founded Date:
2004
Employees Number:
11-50
Funding Status:
M&A
Estimated Revenue:
$1M to $10M
Register and Claim Ownership